|
Which (1-3),(1-6) Beta Glucan is most effective?
As discussed here:
Which beta glucan?
there has been an independent study - undertaken by FILT
Diagnostics Berlin and supervised by Dr. med. Gunther Becher and Dr. rer. nat. Michael Rothe.
This study compares Glucasan® with 8 other
comparable Beta-Glucan products that claim to 'strengthen immunity'
and demonstrated a dramatic difference between them - here is an
extract from the conclusion:
The Glucasan® Product produced the
highest increases of radical formation in activated phagocytes (100%,
left column below), followed by the Products D (84%), H (53%) and L
(12%), whereas the activation rate of the other products was below 5%.
Illustrated is radical formation and
phagocytosis in human and porcine phagocytes (relative units).

The Graph below shows the influence of the
various products on the synthesis of the chemokine interleukin-8. The
Glucasan® Product exerted the
strongest influence (100%), followed by Product H with 71%, Product L
with 64%, Product D with 58%, and Product M with 10%. The remaining
Products B, I and N did not produce any effect at all.
Illustrated is the
Interleukin-8 synthesis in phagocytes:

Ranking positions of products of
similar application according to the respective manufacturers
(strengthening of the immune system, immunomodulation). The numerical
values represent the mean values (Mean) of the ranking positions
obtained for the potency of the respective products with regard to
radical formation (RF), interleukin-8 synthesis (IL8), and neopterin
synthesis (Neopterin).
|
Product |
Mean |
(RF,IL8,Neopterin) |
|
Glucasan® |
1.7 |
(1,1,3) |
|
L |
2.7 |
(4,3,1) |
|
H |
4.0 |
(3,2,7) |
|
D |
4.0 |
(2,4,6) |
|
M |
4.3 |
(5,6,2) |
|
F |
5.7 |
(9,5,3) |
|
N |
6.3 |
(8,8,3) |
|
B |
7.3 |
(6,8,8) |
|
I |
8.0 |
(7,8,9) |
The numerical values
represent the inverse mean values (1/mean) of the ranking positions of
each of the products, based on the potency elicited in radical
formation, interleukin-8 synthesis, and neopterin synthesis (see Table
above). Values are reported as percentages in the chart below.
 Both the
Table and Chart above show that the products can be allocated to three
groups: the
Glucasan® product and Product
L lead in the rank list, the Products I, B and N are at the bottom,
while Products H, D, M and F hold intermediate positions.
For an analysis of the study click here - complete study
available on request.
For further details of the Glucasan product
click here |